PRE and AFTER Market Discussion Thread ( $XYZ or #Subject REQIUIRED in EACH post, TIA )This micro-blog is specifically for a discussion of equities trading in Pre-Market or After-Market, Or Extremely URGENT, verifiable News relating to Global Markets.
It may also include certain nuances in specific markets and sharing of information with others on their Standard Operating Procedures, as well as access to those markets.
Have FUN, keep it real and enjoy each others company, tidbits of advice, humor, expertise or lack thereof. The Gummunity is a Sharing and Caring environment; Please Keep It Clean.
Bes2ALL! – >>>–BenJammmin’——->
This is a discussion topic or guest posting submitted by a Stock Gumshoe reader. The content has not been edited or reviewed by Stock Gumshoe, and any opinions expressed are those of the author alone.
$RKDA up 30% at $9.00 in #premarket. Arcadia Biosciences, Shriram Bioseed reach milestone in developing extended shelf life tomatoes. https://twitter.com/Super1NYC/status/1019892455272050689
$TEUM > Pareteum Signs $2 Million Agreement with US Wireless Internet Services Provider
Rural Operator Expands Cellular and Broadband Mobility Offerings with 3 Year Contract
NEW YORK, NEW YORK – PRNewswire – July 19, 2018 – Pareteum Corporation (NYSE American: TEUM), (“Pareteum” or the “Company”), the rapidly growing Global Cloud Software company, delivering award winning mobile enablement solutions, announced today that a rural U.S. provider of wireless internet services (WISP) has awarded Pareteum a 3-year $2 million agreement for its mobility enablement software services provided through TEUM’s Global Cloud Services Platform (GCSP).
The agreement provides this customer with new software capabilities for mobility services to offer their enterprise customers, expanding beyond Wireless ISP (WISP) services into smartphone and mobile services. These new capabilities, provided to our customer from Pareteum’s software based cloud, open new markets throughout U.S. and internationally. With a broader range of mobile service solutions, including global wireless broadband, SMS, and voice calling, our customer has a new business and profit model as compared to its historic role as a turnkey wireless solutions reseller. End-retail customers will benefit from the variety of packages that can now be tailored to suit their needs and usage, at rates that are substantially lowered.
“Pareteum’s easy-to-adapt solution showcases the strength of our cloud platform to service customers anywhere and everywhere with a single ubiquitous platform. With ease of use and support from the TEUM, we are continuously opening new revenue streams for our clients and therefore us,” commented Vic Bozzo, Chief Executive Officer of Pareteum.
Hal Turner, Pareteum’s Executive Chairman and Principal Executive Officer, stated, “Our newest client represents another step in achieving Pareteum’s global aim of delivering software that enables affordable open mobility and open applications for everyone in the world. We are pleased to empower our client with the Pareteum world-class software cloud platform solution, as we expand further, serving more and more connections (people and devices) globally.”… Best
$KALTF >
Kalytera to Enter Medical Cannabis Market With Focus on Treatment of Psoriasis and Menstrual Cramps
Website Home: https://kalytera.co/
News and Insights: https://kalytera.co/news/ 🙂 Best2YOU! 🙂
$BIOC > Biocept Reminds Investors of Today’s Deadline to be a Shareholder of Record
Arch Therapeutics Appoints Healthcare Industry Executive Punit Dhillon to Board of Directors https://ir.archtherapeutics.com/press-releases/detail/510
TGIF #Best2YOU!
$KALTF > Kalytera and Former Shareholders of Talent Biotechs Agree to Deferment of Milestone Payments Website Home: https://kalytera.co/
News and Insights: https://kalytera.co/news/ Best
$AKAO > Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI) http://investors.achaogen.com/news-releases/news-release-details/achaogen-launches-zemdritm-plazomicin-once-daily-aminoglycoside Best
$AKAO > Achaogen Launches ZEMDRI™ (plazomicin), a Once-Daily Aminoglycoside for use in complicated Urinary Tract Infections (cUTI) http://investors.achaogen.com/news-releases/news-release-details/achaogen-launches-zemdritm-plazomicin-once-daily-aminoglycoside Best
# BEN, always GR8 to read your posts and the wealth of info you share. has been awhile since i even been on a computer, so just started again. Currently long $AUPH, $TRXC, $SGMO and just took a started position with $CVRS. As for $AUPH hopefully some movement by year end with their DES. $TRXC , in june they submitted another 510 for more instruments and more sales looming. Thanks again Ben for your info, will be back more now that the wife is somewhat better…best to all….John
$CLRB ow > Hi John. It’s great to hear from you!
Glad to hear that your wife is better.
Yes $CLRB completed their 1:10 reverse split.
Still wow $AUPH; looking forward to read outs. I am unable to invest in $TRXC because of past history; choose to avoid; too many other great companies with ethics. You’ve piqued my interest with $CVRS; shall DD.
Looking forward to hearing from you often. 🙂 #Best2You! 🙂
$CRVS > Corindus Announces Significant Progress in the Development of Remote Vascular Robotic Technology with the CorPath GRX® System https://investors.corindus.com/investors/news-and-events/press-releases/press-release-details/2018/Corindus-Announces-Significant-Progress-in-the-Development-of-Remote-Vascular-Robotic-Technology-with-the-CorPath-GRX-System/default.aspx #Best2ALL!
$CWBR Wow relevant > Scientists reverse aging-associated skin wrinkles and hair loss in a mouse model, by turning off the gene responsible for mitochondrial dysfunction that drives age-related diseases. https://www.nature.com/articles/s41419-018-0765-9 …
ty https://twitter.com/ajitjohnson_n/status/1020931727772901376
$CWBR relevant > The Most Important Asset
Posted July 17, 2018 by Nick Maggiulli
Rethinking How To View Your Time via Ian Cassel, Thank you!
https://ofdollarsanddata.com/the-most-important-asset/
Truth is a deep kindness that teaches us to be content in our everyday life and share with the people the same happiness. ~ Khalil Gibran
Thanks for reminding me. Excellent article
Closely-held Omeq Medical is the subject of our Feature this week as co-founder and CEO, Lior Margalit, discusses the company’s smart device designed to allow physicians to administer safe and accurate epidural injections.
Of special interest in our Briefs section was Profound Medical (TSX:PRN; OTCQX:PRFMF) uplisting to the Toronto Stock Exchange from the TSX Venture Exchange; Clearside Biomedical (NASDAQ:CLSD) naming Carol Hoang as VP of medical affairs; and a Parkinson’s Foundation study estimating that 1.2 million people in the U.S. will be living with the disease in 2030, up from 930,000 in 2020.
In Wall Street news, Roth initiated coverage of Kalvista Pharmaceuticals (NASDAQ:KALV) at “buy” with a price target of $20; Laidlaw started coverage of Clearside Biomedical at “buy” with a $18 price target; and Stifel launched coverage of Galmed Pharmaceuticals (NASDAQ:GLMD) at “buy” with a price target of $35. In addition, William Blair initiated coverage of Rocket Pharmaceuticals (NASDAQ:RCKT) and Kezar Life Sciences (NASDAQ:KZR) at “outperform” with fair value estimates of $32 and $25, respectively. Also, HCW launched coverage of Syndax Pharmaceuticals (NASDAQ:SNDX), Adamas Pharmaceuticals (NASDAQ:ADMS) and Sol-Gel Technologies (NASDAQ:SLGL) with “buy” ratings and price targets of $30, $45 and $21, respectively. In addition, Ladenburg initiated coverage of Exicure (OTCQB:XCUR) and ContraFect (NASDAQ:CFRX) with “buy” ratings and price targets of $18 and $3, respectively; and upgraded Vericel (NASDAQ:VCEL) to “buy” from “neutral” and introduced a price target of $13. Also, Leerink downgraded Regulus Therapeutics (NASDAQ:RGLS) to “market perform” from “outperform” and slashed its price target to 35 cents from $2, and launched coverage of Krystal Biotech (NASDAQ:KRYS) at “buy” with a $29 fair value estimate.
Your friends at BioTuesdays.com July 17, 18 edition.
$LEAP ow > Leap Therapeutics Announces Collaboration with Merck KGaA, Darmstadt, Germany, and Pfizer to Evaluate Combination of TRX518, Avelumab, and Chemotherapy in Advanced Solid Tumors http://investors.leaptx.com/phoenix.zhtml?c=254460&p=irol-newsArticle&ID=2359396 Have an awesome week and beyond. Best
$LPTX July presentation (Thank you OneMD ) https://www.leaptx.com/file.cfm/1/docs/Leap%20Non-Con%20July%202018%20Update.pdf Best
$APRO ow > Aptose To Release Second Quarter Ended June 30, 2018 Financial Results and Hold Conference Call on August 7, 2018 http://globenewswire.com/news-release/2018/07/24/1541102/0/en/Aptose-To-Release-Second-Quarter-Ended-June-30-2018-Financial-Results-and-Hold-Conference-Call-on-August-7-2018.html Best
$TEUM > Pareteum Awarded $5 Million Contract from Singapore-Based Mobile Solutions Company
Enabling Mobility and E-Commerce via One Integrated Software Applications View
NEW YORK, NEW YORK – PRNewswire – July 24, 2018 – Pareteum Corporation (NYSE American: TEUM), (“Pareteum” or the “Company”), the rapidly growing Global Cloud Software company, delivering award winning mobile enablement solutions, announced today that a Singapore-based provider of worldwide concierge and travel solutions has signed a 3-year $5 million agreement to utilize Pareteum’s Global Cloud Services Platform. Through the Pareteum enabling software and mobility platform, our new customer will expand its existing partnerships with Asian airports that facilitate mobile services to enterprise customers.
Pareteum’s Global Cloud Services Platform (GCSP) solution provides our newest client one fully integrated software applications view, and, will manage their enterprise customers’ requirements as they travel and communicate from virtually anywhere, globally. Pareteum, and its award-winning software enablement cloud, were selected by this Singapore customer because of the multiple applications available through a single view interface, which includes end-to-end service, our competitive pricing, platform flexibility, service management and fulfillment capabilities. The service offerings will be monitored, metered, rated, and billed via Pareteum’s GCSP. Additionally, Pareteum’s e-commerce and self-care solutions will produce the ultimate flexibility for the end user, as well as access to worldwide WIFI options, providing a wider reach in connectivity.
“Pareteum’s growth throughout Asia is encouraging. The market potential in the Asian region is exponential and Pareteum aims to claim the large majority of that market, one satisfied client at a time,” commented Vic Bozzo, Chief Executive Officer of Pareteum.
Hal Turner, Pareteum’s Executive Chairman and Principal Executive Officer, said, “Pareteum’s growth has been and will continue to reflect our story of disruption and innovation, bringing choice and flexible solutions for our clients. It is from the TEUM’s efforts, expended daily, that we are reaping the business results, and proving the points of our company’s attractiveness, both to current and prospective customers and investors. This newest client exemplifies another step in our growth as a company, which is rapidly defining Pareteum as the go to Super API and Global Cloud Software Mobility Enabler, virtually on demand!” Best
$MYSZ > Go Ecommerce Tel-Aviv https://ir.mysizeid.com/press-releases/
DATE: 25th July 2018
Go eCommerce 6 will be held under the main theme “What’s your e factor?” and will showcase companies’ fascinating success stories and discuss the many challenges on the way to success.
This is the biggest eCommerce event in Israel for the sixth year, and MySize is not going to miss it!
Come meet us at the Go eCommerce 2018, in David Intercontinental Hotel, 12 Kaufman St. Tel Aviv #Best2ALL!
$MYSZ > Go Ecommerce Tel-Aviv https://ir.mysizeid.com/press-releases/
DATE: 25th July 2018
Go eCommerce 6 will be held under the main theme “What’s your e factor?” and will showcase companies’ fascinating success stories and discuss the many challenges on the way to success.
This is the biggest eCommerce event in Israel for the sixth year, and MySize is not going to miss it!
Come meet us at the Go eCommerce 2018, in David Intercontinental Hotel, 12 Kaufman St. Tel Aviv #Best2ALL!
$TEUM > Pareteum Awarded $3 Million 5-Year Contract in North Africa
Cloud Mobility Enablement Expands Operator’s Markets and Services Offerings
NEW YORK, NEW YORK – PRNewswire – July 25, 2018 – Pareteum Corporation (NYSE American: TEUM), (“Pareteum” or the “Company”), the rapidly growing Global Cloud Software company, delivering award winning mobile enablement solutions, announced today that it has signed a $3 million 5-year agreement to provide its Managed Service Platform (MSP) to a North-African based MVNE provider.
Pareteum’s Managed Services Platform provides the client with a fully-integrated software solution, delivering multi-country branded services, digital applications, data services and traditional mobile services for its end-users. Pareteum’s software API based mobility enablement cloud, with global connectivity, facilitates expansion into adjacent countries, with a focus on French-speaking countries in Africa and the Middle East.
Vic Bozzo, CEO of Pareteum, stated, “Pareteum is pleased to empower this client with our MSP platform. As the digital economy takes over, the African and Middle East regions are rapidly growing in connections and show a lot of interest in software solutions for their expanding needs. Pareteum is a key partner in this wave of connectivity, bringing the best services, at faster speeds, via safe and secure APIs, to these flourishing markets.”
Hal Turner, Executive Chairman and Principal Executive Officer of Pareteum, commented, “Pareteum’s continued extension of our mission is best represented with this newest customer. We seek to create geographical freedom for our users, with a platform that provides a flexible solution, without heavy capital investment in infrastructure, generating opportunities for all. The combined effectiveness of our software solutions will bring forth a new era of innovation, unlocking the limitless potential of clients with our software services!”
About Pareteum: Best
$MGXMF > MGX Minerals Announces Acquisition of Salinitas Lithium Brine Project at Salinas Grande Salar, Argentina
VANCOUVER, BRITISH COLUMBIA / July 25, 2018 / MGX Minerals Inc. (“MGX” or the “Company”) (CSE: XMG / OTCQB: MGXMF / FKT: 1MG) is pleased to announce it has entered into an Option Agreement (the “Agreement”) with A.I.S. Resources (TSX.V: AIS) to acquire an 80% interest in the Salinitas lithium brine mining tenements (“Salinitas” or the “Project”) located in the lithium triangle of Argentina, Salar de Salinas Grandes, Province of Salta. The 4,308-hectare contiguous land package resides in the Puna region of northwest Argentina near the border of Chile, an area renowned for its lithium and potassium rich brine resources.
The surface elevation of the Salinas Grandes salar is approximately 3,400 metres above sea level. The salar forms a composite closed basin with internal drainage, where discharge occurs by evaporation. Water inflow into the salar is produced by precipitation, superficial and groundwater incursions. MGX plans to conduct a Transient Electromagnetic Method (TEM) geophysical study along with trenching, which will be followed by a drill program along the edge of the salar, to test for shallow, near surface brines and determine locations with anomalous concentrations of lithium.
Figure 1. General Location Map of Argentina’s Puna
MGXMinerals72520181
Figure 2. Location Map of Concessions in the Salar De Salinas Grandes
MGXMinerals72520182
To secure the Option Agreement, MGX has agreed to pay US$250,000 on or before July 31,2018. The Company can acquire an undivided 80% in the Project at any time during the Agreement by making payments totaling US$3.2 million. MGX has also agreed to incur total expenditures of at least US$1.2 million prior to May 31, 2020.
Rapid Lithium Brine Extraction Technology
MGX has developed a rapid lithium extraction technology eliminating or greatly reducing the physical footprint and investment in large, multi-phase, lake sized, lined evaporation ponds, as well as enhancing the quality of extraction and recovery across a complex range of brines as compared with traditional solar evaporation. This technology is applicable to petrolithium (oil and gas wastewater), natural brine, and other brine sources such as lithium-rich mine and industrial plant wastewater. The technology was recently chosen as winner of the Base and Specialty Metals Industry Leadership Award at the 2018 S&P Global Platts Global Metals Awards, held in London in May (see press release dated May 18, 2018).
Qualified Person
Andris Kikauka (P. Geo.), Vice President of Exploration for MGX Minerals, has prepared, reviewed and approved the scientific and technical information in this press release. Mr. Kikauka is a non-independent Qualified Person within the meaning of National Instrument 43-101 Standards…. Best
$IMEXF > Imagin Medical Announces Stock Options Granted
8:30 am ET July 25, 2018 (Globe Newswire)
Imagin Medical (CSE:IME) (OTCQB:IMEXF) (Frankfurt & Stuttgart Symbol:DPD2) (the “Company”) announced today that, pursuant to the Company’s Stock Option Plan, an aggregate of 500,000 shares have been granted to certain consultants as incentive stock options at an exercise price of $0.16 per share. The options are exercisable for a period of five years, ending on July 25, 2023.
About Imagin Medical
Imagin is developing powerful new imaging solutions for the detection and visualization of cancer. The Company believes its technology will radically improve physicians’ ability to detect cancer with minimally invasive endoscopes, improving their ability to visualize, identify and remove cancerous cells. Imagin’s initial target market is bladder cancer, the sixth most common cancer in the U.S., and the costliest cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, Imagin’s advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors. Learn more at http://www.imaginmedical.com.
Forward-Looking Statements
Information set forth in this news release contains forward-looking statements. These statements reflect management’s current estimates, beliefs, intentions and expectations; they are not guarantees of future performance. The Company cautions that all forward-looking statements are inherently uncertain, and that actual performance may be affected by a number of material factors, many of which are beyond the Company’s control. Accordingly, actual and future events, conditions and results may differ materially from the estimates, beliefs, intentions and expectations expressed or implied in the forward-looking information. Specifically, there is no assurance the Company’s imaging system will work in the manner expected. Except as required under applicable securities legislation, the Company undertakes no obligation to publicly update or revise forward-looking information. The CSE has neither approved nor disapproved the information contained herein and does not accept responsibility for the adequacy or accuracy of this news release.
Contacts:
Stephen Kilmer, Investor Relations $0.1144 #Best2All!